ArticleInternational journal of rheumatic diseases2026
Comparative Safety Analysis of Targeted Synthetic and Biologic Disease-Modifying Antirheumatic Drugs Among Patients With Rheumatoid Arthritis: A Nationwide Cohort Study in Japan.
Shiori Nishimura et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.